Materials Healthcare Sector

Enhabit

Market Cap: US$544.9m

Provides home health and hospice services in the United States.

Regulus Therapeutics

Market Cap: US$543.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Cogent Biosciences

Market Cap: US$543.5m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Owens & Minor

Market Cap: US$543.2m

Operates as a healthcare solutions company worldwide.

RxSight

Market Cap: US$540.9m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

Axogen

Market Cap: US$536.5m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Eton Pharmaceuticals

Market Cap: US$528.3m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Stoke Therapeutics

Market Cap: US$525.8m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Tyra Biosciences

Market Cap: US$524.3m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Clarity Pharmaceuticals

Market Cap: AU$803.4m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Kura Oncology

Market Cap: US$515.1m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Auna

Market Cap: US$514.1m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

CytoDyn

Market Cap: US$504.7m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Healius

Market Cap: AU$784.2m

Provides specialty diagnostic services to consumer and practitioners in Australia.

Talkspace

Market Cap: US$500.3m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Maravai LifeSciences Holdings

Market Cap: US$499.1m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Mind Medicine (MindMed)

Market Cap: US$494.9m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Definitive Healthcare

Market Cap: US$485.8m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Botanix Pharmaceuticals

Market Cap: AU$752.3m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Elite Pharmaceuticals

Market Cap: US$482.4m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Relay Therapeutics

Market Cap: US$478.3m

Operates as a clinical-stage precision medicines company.

Orthofix Medical

Market Cap: US$478.0m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

Castle Biosciences

Market Cap: US$475.8m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Upstream Bio

Market Cap: US$472.3m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Altimmune

Market Cap: US$468.8m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Sonida Senior Living

Market Cap: US$468.2m

Owns and operates senior housing communities in the United States.

PYC Therapeutics

Market Cap: AU$723.2m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Zevra Therapeutics

Market Cap: US$460.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Allergy Therapeutics

Market Cap: UK£345.6m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Cross Country Healthcare

Market Cap: US$457.3m

Provides talent management services for healthcare clients in the United States.

Theravance Biopharma

Market Cap: US$457.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Arvinas

Market Cap: US$456.9m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

UroGen Pharma

Market Cap: US$454.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Paragon Care

Market Cap: AU$703.5m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.